• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imation purchase boosts Kodak’s sales

Article

Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998’s $442 million, which Kodak attributed to its 1998 acquisition

Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998’s $442 million, which Kodak attributed to its 1998 acquisition of Imation’s medical imaging business in a deal worth $520 million (SCAN 8/19/98). For the year, revenues climbed 39% to $2.1 billion from the previous year’s $1.5 billion.

The Rochester, NY-company’s Health Imaging Group also saw dramatic increases in earnings from operations, which rose 232% for the quarter from $38 million in 1998 to $126 million. For the year, the group posted operating earnings of $470 million, up 46% from 1998’s $321 million.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.